Seoulin Bioscience Co.,Ltd.
Financials
Valuation Metrics
Seoulin Bioscience Co.,Ltd.'s Market Cap is ₩339B. At end of 2025 it was ₩605B. Ranked #1959 of 2,405 in KR market (top 81%), #1227 of 1,627 on KOSDAQ (top 75%), #209 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 90%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 33.85B KRW | KR#1,959/2,405 Sec#209/231 |
| Revenue | 83.17B KRW | KR#1,524/2,405 Sec#96/231 |
| Net Income | 844.7M KRW | KR#1,492/2,405 Sec#103/231 |
| Total Assets | 115.24B KRW | KR#1,670/2,405 Sec#132/231 |
| Net Assets | 85.63B KRW | KR#1,529/2,405 Sec#122/231 |
| Employees | 110 | KR#1,569/2,405 Sec#123/231 |
| Value | ||
| P/E | 40.08x | KR#1,385/2,405 Sec#88/231 |
| P/B | 0.40x | KR#647/2,405 Sec#24/231 |
| PEG | 0.00x | KR#20/2,405 Sec#1/231 |
| P/S | 0.41x | KR#839/2,405 Sec#34/231 |
| EV/EBITDA | 74.24x | KR#1,450/2,405 Sec#95/231 |
| Profitability | ||
| ROE | 0.99% | KR#1,482/2,405 Sec#102/231 |
| ROA | 0.73% | KR#1,436/2,405 Sec#101/231 |
| Op. Margin | 0.61% | KR#1,543/2,405 Sec#109/231 |
| Revenue Growth | 17.13% | KR#617/2,405 Sec#57/231 |
| Earnings Growth | 40684.69% | KR#1/2,405 Sec#1/231 |
| Financial Health | ||
| Debt Ratio | 34.58% | KR#676/2,405 Sec#79/231 |
| Total Debt | 12.89B KRW | KR#1,535/2,405 Sec#135/231 |
| Cash | 9.32B KRW | KR#1,729/2,405 Sec#148/231 |
| Current Ratio | 2.73x | KR#618/2,405 Sec#82/231 |
| Net Debt/EBITDA | 7.08x | KR#1,127/2,405 Sec#84/231 |
| Dividend | ||
| Div. Yield | 2.69% | KR#765/2,405 Sec#40/231 |
| Div. Growth | 0.00% | KR—/2,405 Sec—/231 |
| Performance | ||
| 1Y Return | -41.64% | KR#1,769/2,405 Sec#150/231 |
| 1M Return | -9.68% | KR#1,130/2,405 Sec#109/231 |
| From 52W High | -53.18% | KR#1,314/2,405 Sec#105/231 |
| 1Y MDD | -47.31% | KR#836/2,405 Sec#67/231 |
| Trading | ||
| Volume | 5,869 shares | KR#2,050/2,405 Sec#206/231 |
| Trading Value | 21.1M KRW | KR#2,078/2,405 Sec#214/231 |
| Foreign Own. | 1.96% | KR#1,639/2,405 Sec#160/231 |
| Per Share | ||
| EPS | 91 KRW | KR#1,438/2,405 Sec#97/231 |
| BPS | 9,207 KRW | KR#1,054/2,405 Sec#72/231 |
Company Info
SEORIN BIO, founded in 1984, converted to a corporation in 1994, and listed on KOSDAQ in 2005, is a specialized bio company. It provides raw and subsidiary materials for biopharmaceuticals and reagents/equipment for basic life science research, offering total solutions across the bio industry with over 58,000 items. The company supplies core raw materials like cell culture media through global partnerships and supports customer R&D with its industry experience and cold chain logistics infrastructure. SEORIN BIO is headquartered in Seongnam-si, Gyeonggi-do.